Dambkowski Carl bought ORKA
May 21, 2026 · Form 4 insider transaction
Dambkowski Carl bought 38,689 shares of Oruka Therapeutics, Inc. at $6.84 per share, a transaction worth $264.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
38,689
Price
$6.84
Total value
$264.6K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 21, 2026
Filing dateMay 22, 2026
Shares owned after155,172
OwnershipDirect
10b5-1 planNo
AmendedNo